InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
3
T+90 hit rate
100%
T+90 mean return
+72.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by O'Connor Daniel J., Chief Executive Officer. Insider active across 6 companies, notably ONCOSEC MEDICAL Inc. Cumulatively, 9 reports have been logged. Split: 1 buy · 3 sells. Total volume traded: €499k. History available since 30 April 2021. The latest transaction was filed on 11 December 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations9 total
48,202 sharesCommon StockSEC:0000950170-24-028190:0
750,000 shares0Common StockSEC:0000950170-23-069446:0
50,012 shares@ US$9.82100.0% of flowCommon StockSEC:0000950170-23-056943:0
2,750,000 shares0Ordinary SharesSEC:0001209191-23-026093:0
1,377,598 shares0Common StockSEC:0001493152-22-035477:0
16,000 shares@ US$0.6118100.0% of flowCommon StockSEC:0001136261-22-000249:0
Ideal exit: 26 Feb 2023 (T+270)
42,005 shares0Class A Common StockSEC:0001213900-22-011644:0
3,172 shares@ US$4.8650.0% of flowCommon StockSEC:0001493152-21-010454:0
3,172 shares@ US$4.8650.0% of flowCommon StockSEC:0001493152-21-010454
9 of 9 declarations
About O'Connor Daniel J.
Daniel J. O'Connor is the Chief Executive Officer and President of OncoSec Medical Inc., Larkspur Health Acquisition Corp., and Seelos Therapeutics, Inc. He is responsible for the strategic and operational direction of these companies, overseeing product development and research initiatives. With a strong background in the biopharmaceutical sector, he is committed to promoting innovation and developing treatments that meet patient needs.
